IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Deep Track Capital, LP

Q1 2023 Holdings

Filed 2023-05-15 | 58 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
89Bio Inc(ETNBGBP)PutCOM282559103$67.0K4,4000.0%
Nektar Therapeutics(NKTREUR)COM640268108$1.2M1,743,2480.1%
Immunogen Inc(IMGNEUR)PutCOM45253H101$1.6M428,1000.1%
Century Therapeutics Inc(IPSC)COM15673T100$3.5M1,022,8920.1%
2Seventy BIO Inc(TSVT*)COMMON STOCK901384107$3.6M350,0000.1%
Immunic Inc(IMUX)COM4525EP101$3.8M2,524,2420.2%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$4.0M499,4000.2%
Nkarta Inc(NKTX)COM65487U108$4.8M1,354,2000.2%
Heron Therapeutics Inc(HRTX)COM427746102$4.9M3,234,7220.2%
Orchard Therapeutics PLCSPON ADS NEW68570P200$6.3M1,166,6700.3%
Relmada Therapeutics Inc(RLMD)COM75955J402$6.4M2,837,8180.3%
Jounce Therapeutics Inc(JNCEEUR)COM481116101$7.9M4,259,6530.3%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$10.5M571,2330.4%
Silence Therapeutics PLC(SLN)ADS82686Q101$12.1M1,951,5800.5%
Nuvation BIO Inc(NUVB)COM CL A67080N101$12.8M7,720,6880.5%
Aclaris Therapeutics Inc(ACRS)COM00461U105$13.8M1,708,9710.6%
Allakos Inc(ALLKGUSD)COM01671P100$16.0M3,585,0000.7%
Acumen Pharmaceuticals Inc(ABOS)COM00509G209$16.0M3,952,0000.7%
Point Biopharma Global IncCOM730541109$17.0M2,345,0730.7%
Uniqure NV(QURE)SHSN90064101$17.4M865,7670.7%
Inozyme Pharma IncCOM45790W108$18.6M3,250,0000.8%
Vigil Neuroscience Inc(VIGL)COM92673K108$19.8M2,025,1370.8%
Edgewise Therapeutics Inc(EWTX)COM28036F105$20.5M3,068,2590.8%
Deciphera Pharmaceuticals in(DCPHEUR)COM24344T101$21.1M1,363,2010.9%
Astria Therapeutics Inc(CATBUSD)COM04635X102$24.2M1,816,5311.0%
Intellia Therapeutics Inc(NTLA)COM45826J105$26.3M704,5331.1%
Nurix Therapeutics Inc(NRIX)COM67080M103$26.6M2,997,8301.1%
Repare Therapeutics Inc(RPTX)COM760273102$26.8M2,727,6061.1%
Dyne Therapeutics Inc(DYN)COM26818M108$26.9M2,334,6331.1%
89Bio Inc(ETNBGBP)COM282559103$27.4M1,800,0001.1%
Autolus Therapeutics PLC(AUTL)SPON ADS05280R100$27.6M15,000,0001.1%
Viridian Therapeutics Inc(VRDN)COM92790C104$31.3M1,230,2591.3%
Argenx SE(ARGX)PutSPONSORED ADR04016X101$37.3M100,0001.5%
Exelixis Inc(EXEL)COM30161Q104$37.5M1,931,8741.5%
Beam Therapeutics Inc(BEAM)COM07373V105$38.3M1,250,0001.6%
4D Molecular Therapeutics in(FDMT)COM35104E100$39.2M2,278,1071.6%
Pacific Biosciences Calif in(PACB)COM69404D108$40.6M3,504,3901.7%
Seagen Inc(SGENUSD)PutCOM81181C104$44.1M217,8001.8%
Agenus Inc(AGENEUR)COM NEW00847G705$45.6M30,000,0001.9%
Dice Therapeutics IncCOM23345J104$45.8M1,600,0001.9%
Biogen Inc(BIIB)COM09062X103$55.6M200,0002.3%
Geron Corp(GERN)COM374163103$58.3M26,867,4792.4%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$60.0M2,819,0452.5%
Dynavax Technologies Corp(DVAX)COM NEW268158201$62.3M6,350,0002.6%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$63.0M2,646,7822.6%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$64.0M3,187,4152.6%
Reata Pharmaceuticals Inc(RETAEUR)CL A75615P103$66.3M729,0002.7%
Chinook Therapeutics Inc(290A)COM16961L106$69.5M3,000,0002.9%
Springworks Therapeutics IncCOM85205L107$79.8M3,100,0003.3%
Alkermes PLC(ALKS)SHSG01767105$84.6M3,000,0003.5%
Page 1 of 2Next